Product
Agalsidase Alpha
1 clinical trial
1 indication
Indication
Fabry DiseaseClinical trial
A Multi-country Time and Motion Study to Describe the Experience of Clinicians, Patients and Their Caregivers During the Treatment of Fabry Disease With Enzyme Replacement Therapy With Agalsidase Alfa and Agalsidase BetaStatus: Completed, Estimated PCD: 2022-05-18